Alpha-enolase: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
[[Category:Cancer biomarkers]] | [[Category:Cancer biomarkers]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 03:42, 17 March 2025
Alpha-enolase (also known as ENO1) is an enzyme that in humans is encoded by the ENO1 gene. It is one of three enolase isoenzymes found in mammals; this isoenzyme is found in most tissues in the body, and a homodimer composed of two alpha subunits constitutes the most common form.
Function[edit]
Alpha-enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP), a key step in the glycolysis pathway. This reaction involves the abstraction of a proton from the 2-carbon of 2-PG to form a carbonyl group, followed by the transfer of a phosphate group from the 3-carbon to the 2-carbon to form PEP.
Clinical significance[edit]
Alpha-enolase has been identified as an autoantigen in severe forms of autoimmune diseases, such as rheumatoid arthritis and Hashimoto's encephalopathy. It is also overexpressed in several types of cancer, including lung cancer, breast cancer, and colorectal cancer, and has been suggested as a potential biomarker for these conditions.
See also[edit]
References[edit]
<references />
External links[edit]
| Enzymes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Hypersensitivity and autoimmune diseases (279.5–6) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Cancer biomarkers | ||||||||
|---|---|---|---|---|---|---|---|---|
This cancer biomarker related article is a stub.
|
